ASTRAZENECA PHARMACEUTICALS LP. V. APOTEX CORP. , No. 11-1182 (Fed. Cir. 2012)
Annotate this CaseThis opinion or order relates to an opinion or order originally issued on February 9, 2012.
Download PDF
United States Court of Appeals for the Federal Circuit ______________________ February 9. 2012 ERRATA ______________________ 2011-1182, -1183, -1184, -1185, -1186, -1187, -1188, -1189, -1190 ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, IPR PHARMACEUTICALS INC., and THE BRIGHAM AND WOMEN S HOSPITAL, INC., Plaintiffs-Appellants, v. APOTEX CORP., Defendant-Appellee, and AUROBINDO PHARMA LIMITED, Defendant-Appellee, and COBALT PHARMACEUTICALS INC. and COBALT LABORATORIES INC., Defendants-Appellees, and GLENMARK GENERICS INC. USA, Defendant-Appellee, and MYLAN PHARMACEUTICALS INC., Defendant-Appellee, and PAR PHARMACEUTICALS, INC., Defendant-Appellee, and SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendant-Appellee, and TEVA PHARMACEUTICALS USA, INC., Defendant-Appellee, and TORRENT PHARMA INC. and TORRENT PHARMACEUTICALS LTD., Defendants. ______________________ Decided: February 24, 2012 Precedential Opinion ______________________ Please make the following change: Page 3, correction of Shane A. Brunner, Mechant & Gould, P.C. of Madison, Wisconsin, argued for defendant-appellee Aurobindo Pharma Limited H. Ketto Sabharwal to H. Keeto Sabharwal
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
